The evolution of breast imaging: Past to present

Radiology

Volumn 273, Issue 2, 2014, Pages S23-S44

  Joe, Bonnie N ^a   Sickles, Edward A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST BIOPSY; BREAST CANCER; BREAST DENSITY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER MORTALITY; CLINICAL EFFECTIVENESS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIFFUSION WEIGHTED IMAGING; DIGITAL BREAST TOMOSYNTHESIS; DIGITAL MAMMOGRAPHY; ECHOMAMMOGRAPHY; HUMAN; IMAGE ANALYSIS; IMAGE GUIDED BIOPSY; IMAGE PROCESSING; IMAGE QUALITY; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RADIATION BEAM; RADIATION DOSE; RADIATION EXPOSURE; RADIATION HAZARD; RADIATION SAFETY; REVIEW; SCREEN FILM MAMMOGRAPHY; THERMOGRAPHY; XEROMAMMOGRAPHY; BREAST NEOPLASMS; DEVICES; EARLY DIAGNOSIS; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; HISTORY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; RADIOLOGY; SENSITIVITY AND SPECIFICITY;

BIOPSY, FINE-NEEDLE; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; PROGNOSIS; RADIOGRAPHIC IMAGE ENHANCEMENT; RADIOLOGY; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, MAMMARY;

EID: 84922394044     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.14141233     Document Type: Review

References (191)

1. Clopton MB. The difficulty of diagnosis of carcinoma of the breast. Radiology 1925;4(5): 390-394.
2. Egan RL. Mammography. Springfield, Ill: Thomas, 1964.
3. Menville LJ, Doub HP. Early diagnosis of breast carcinoma. Radiology 1938;30(2): 258-259.
4. Smith RA, Duffy SW, Tabár L. Breast cancer screening: The evolving evidence. Oncology (Williston Park) 2012;26(5):471-475, 479-481, 485-486.
5. Tabár L, Vitak B, Chen TH, et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 2011;260(3):658-663.
6. Smith RA, Duffy SW, Gabe R, Tabar L, Yen AM, Chen TH. The randomized trials of breast cancer screening: What have we learned? Radiol Clin North Am 2004;42(5): 793-806.
7. Warren SL. A roentgenologic study of the breast. Am J Roentgenol Radium Ther. 1930;24:113-124.
8. Lockwood H. The value of breast radiography. Radiology 1934;23(2):202-207.
9. Hunt HB, Hicken NF. Evaluation of various diagnostic procedures used in the study of the breast, with particular reference to roentgenographic examination. Radiology 1939; 33(6):712-724.
10. Ingleby H, Gershon-Cohen J. Comparative anatomy, pathology and roentgenology of the breast. Philadelphia, Pa: University of Pennsylvania Press, 1960.
11. Egan RL. Experience with mammography in a tumor institution: Evaluation of 1, 000 studies. Radiology 1960;75(6):894-900.
12. Vyborny CJ, Schmidt RA. Mammography as a radiographic examination: An overview. Radio Graphics 1989;9(4):723-764.
13. Yaffe MJ. AAPM tutorial. Physics of mammography: image recording process. Radio Graphics 1990;10(2):341-363.
14. Ostrum BJ, Becker W, Isard HJ. Low-dose mammography. Radiology 1973;109(2):323-326.
15. Strax P, Venet L, Shapiro S. Value of mammography in reduction of mortality from breast cancer in mass screening. Am J Roentgenol Radium Ther Nucl Med 1973; 117(3):686-689.
16. Moskowitz M, Pemmaraju S, Fidler JA, et al. On the diagnosis of minimal breast cancer in a screened population. Cancer 1976;37(5):2543-2552.
17. Beahrs OH, Smart CR. Diagnosis of minimal breast cancers in the BCDDP: The 66 questionable cases. Cancer 1979;43(3):848-850.
18. Smart CR, Byrne C, Smith RA, et al. Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project. CA Cancer J Clin 1997;47(3):134-149.
19. Report of the Working Group to Review the National Cancer Institute-American Cancer Society Breast Cancer Detection Demonstration Projects. J Natl Cancer Inst 1979;62(3):639-709.
20. Byrd BF Jr. Progress report on American Cancer Society/National Cancer Institute Breast Cancer Detection Demonstration Projects. Prog Clin Biol Res 1977;12:177-188.
21. Baker LH. Breast Cancer Detection Demonstration Project: Five-year summary report. CA Cancer J Clin 1982;32(4):194-225.
22. Lopez MJ, Smart CR. Twenty-year follow-up of minimal breast cancer from the Breast Cancer Detection Demonstration Project. Surg Oncol Clin N Am 1997;6(2):393-401.
23. Smart CR. Highlights of the evidence of benefit for women aged 40-49 years from the 14-year follow-up of the Breast Cancer Detection Demonstration Project. Cancer 1994;74(1 suppl):296-300.
24. Larsson LG, Andersson I, Bjurstam N, et al. Updated overview of the Swedish Randomized Trials on Breast Cancer Screening with Mammography: Age group 40-49 at randomization. J Natl Cancer Inst Monogr 1997 (22):57-61.
25. Andersson I, Aspegren K, Janzon L, et al. Mammographic screening and mortality from breast cancer: The Malmö mammographic screening trial. BMJ 1988;297(6654):943-948.
26. Alexander FE, Anderson TJ, Brown HK, et al. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet 1999;353(9168):1903-1908.
27. Lundgren B, Jakobsson S. Single view mammography: A simple and efficent approach to breast cancer screening. Cancer 1976;38(3):1124-1129.
28. Bassett LW, Gold RH. Breast radiography using the oblique projection. Radiology 1983;149(2):585-587.
29. Mancuso S, Ottolenghi G. The oblique projection in the radiologic study of the breast [in Italian]. Minerva Ginecol 1989;41(7): 325-328.
30. Sickles EA, Weber WN, Galvin HB, Ominsky SH, Sollitto RA. Baseline screening mammography: one vs two views per breast. AJR Am J Roentgenol 1986;147(6):1149-1153.
31. Bassett LW, Bunnell DH, Jahanshahi R, Gold RH, Arndt RD, Linsman J. Breast cancer detection: one versus two views. Radiology 1987;165(1):95-97.
32. Hackshaw AK, Wald NJ, Michell MJ, Field S, Wilson AR. An investigation into why two-view mammography is better than one-view in breast cancer screening. Clin Radiol 2000;55(6):454-458.
33. Sickles EA. Case 1: Triangulation by using the oblique view. In: Breast disease III: Test and syllabus. Reston, Va: American College of Radiology, 2001; 1-11.
34. Swann CA, Kopans DB, McCarthy KA, White G, Hall DA. Localization of occult breast lesions: practical solutions to problems of triangulation. Radiology 1987;163(2):577-579.
35. Park JM, Franken EA Jr. Triangulation of breast lesions: Review and clinical applications. Curr Probl Diagn Radiol 2008;37(1):1-14.
36. Pearson KL, Sickles EA, Frankel SD, Leung JW. Efficacy of step-oblique mammography for confirmation and localization of densities seen on only one standard mammographic view. AJR Am J Roentgenol 2000;174(3):745-752.
37. Hall FM, Homer MJ, D'Orsi CJ, Eklund GW. Mammography of the augmented breast. AJR Am J Roentgenol 1989;153(5):1098-1099.
38. Eklund GW, Busby RC, Miller SH, Job JS. Improved imaging of the augmented breast. AJR Am J Roentgenol 1988;151(3):469-473.
39. Sickles EA, Doi K, Genant HK. Magnification film mammography: image quality and clinical studies. Radiology 1977;125(1):69-76.
40. Sickles EA. Microfocal spot magnification mammography using xeroradiographic and screen-film recording systems. Radiology 1979;131(3):599-607.
41. Berkowitz JE, Gatewood OM, Gayler BW. Equivocal mammographic findings: Evaluation with spot compression. Radiology 1989;171(2):369-371.
42. Sickles EA. Combining spot-compression and other special views to maximize mammographic information. Radiology 1989;173(2):571.
43. Sickles EA. Breast imaging: From 1965 to the present. Radiology 2000;215(1):1-16.
44. Frank HA, Hall FM, Steer ML. Preoperative localization of nonpalpable breast lesions demonstrated by mammography. N Engl J Med 1976;295(5):259-260.
45. Goldberg RP, Hall FM, Simon M. Preoperative localization of non palpable breast lesions using a wire marker and perforated mammographic grid. Radiology 1983;146(3): 833-835.
46. Hall FM, Kopans DB, Sadowsky NL, Homer MJ. Development of wire localization for occult breast lesions: Boston remembrances. Radiology 2013;268(3):622-627.
47. Homer MJ, Pile-Spellman ER. Needle localization of occult breast lesions with a curved-end retractable wire: Technique and pitfalls. Radiology 1986;161(2):547-548.
48. Kopans DB, DeLuca S. A modified needlehookwire technique to simplify preoperative localization of occult breast lesions. Radiology 1980;134(3):781.
49. Kopans DB. Standardized mammography reporting. Radiol Clin North Am 1992;30(1):257-264.
50. Burnside ES, Sickles EA, Bassett LW, et al. The ACR BI-RADS experience: learning from history. J Am Coll Radiol 2009;6(12):851-860.
51. Sickles EA. Periodic mammographic follow-up of probably benign lesions: Results in 3, 184 consecutive cases. Radiology 1991;179(2):463-468.
52. D'Orsi CJ, Sickles EA, Mendelson EB, et al. ACR BI-RADS Atlas, Breast Imaging Reporting and Data System. Reston, Va: American College of Radiology, 2013.
53. Sickles EA. The use of breast imaging to screen women at high risk for cancer. Radiol Clin North Am 2010;48(5): 859-878.
54. van Gils CH, Otten JD, Verbeek AL, Hendriks JH. Mammographic breast density and risk of breast cancer: Masking bias or causality? Eur J Epidemiol 1998;14(4):315-320.
55. van Gils CH, Otten JD, Verbeek AL, Hendriks JH, Holland R. Effect of mammographic breast density on breast cancer screening performance: A study in Nijmegen, The Netherlands. J Epidemiol Community Health 1998;52(4):267-271.
56. Pinsky RW, Helvie MA. Mammographic breast density: Effect on imaging and breast cancer risk. J Natl Compr Canc Netw 2010;8(10):1157-1164; quiz 1165.
57. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 1996; 276(1):33-38.
58. Harvey JA, Yaffe MJ, D'Orsi C, Sickles EA. Density and breast cancer risk. Radiology 2013;267(2):657-658.
59. Lipson JA, Hargreaves J, Price ER. Frequently asked questions about breast density, breast cancer risk, and the breast density notification law in California: A consensus document. (CBDIG) CBDIG. http://www.breastdensity.info. Published 2013. Accessed May 27, 2014.
60. Price ER, Hargreaves J, Lipson JA, et al. The California breast density information group: A collaborative response to the issues of breast density, breast cancer risk, and breast density notification legislation. Radiology 2013;269(3):887-892.
61. Pisano ED, Yaffe MJ. Digital mammography. Radiology 2005;234(2):353-362.
62. Pisano ED, Zuley M, Baum JK, Marques HS. Issues to consider in converting to digital mammography. Radiol Clin North Am 2007;45(5):813-830, .
63. Zuley M. How to transition to digital mammography. J Am Coll Radiol 2007;4(3): 178-183.
64. Avrin D, Morin R, Piraino D, et al. Storage, transmission, and retrieval of digital mammography, including recommendations on image compression. J Am Coll Radiol 2006;3(8):609-614.
65. Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 2005;353(17): 1773-1783.
66. Pisano ED, Gatsonis CA, Yaffe MJ, et al. American College of Radiology Imaging Network digital mammographic imaging screening trial: objectives and methodology. Radiology 2005;236(2):404-412.
67. Pisano ED, Hendrick RE, Yaffe MJ, et al. Diagnostic accuracy of digital versus film mammography: Exploratory analysis of selected population subgroups in DMIST. Radiology 2008;246(2):376-383.
68. Hendrick RE. Radiation doses and cancer risks from breast imaging studies. Radiology 2010;257(1):246-253.
69. Dershaw DD, Fleischman RC, Liberman L, Deutch B, Abramson AF, Hann L. Use of digital mammography in needle localization procedures. AJR Am J Roentgenol 1993;161(3):559-562.
70. Zuley ML. The basics and implementation of digital mammography. Radiol Clin North Am 2010;48(5):893-901.
71. U.S. Food and Drug Administration. MQSA national statistics. Silver Spring, Md. http://www.fda.gov/Radiation-EmittingProducts/MammographyQualityStandardsActandProgram/FacilityScorecard/ucm113858.htm Accessed February 17, 2014.
72. Gershon-Cohen J, Haberman JD. Thermography. Radiology 1964;82(2):280-285.
73. Feig SA, Shaber GS, Schwartz GF, et al. Thermography, mammography, and clinical examination in breast cancer screening: Review of 16, 000 studies. Radiology 1977; 122(1):123-127.
74. Moskowitz M, Milbrath J, Gartside P, Zermeno A, Mandel D. Lack of efficacy of thermography as a screening tool for minimal and stage I breast cancer. N Engl J Med 1976;295(5):249-252.
75. Cole-Beuglet C, Beique RA. Continuous ultrasound B-scanning of palpable breast masses. Radiology 1975;117(1):123-128.
76. Damascelli B, Musumeci R, Orefice S. Sonar information about breast tumors. Radiology 1970;96(3):583-586.
77. Kobayashi T. Gray-scale echography for breast cancer. Radiology 1977;122(1):207-214.
78. Taylor KJ, Merritt C, Piccoli C, et al. Ultrasound as a complement to mammography and breast examination to characterize breast masses. Ultrasound Med Biol 2002;28(1):19-26.
79. Stavros AT, Thickman D, Rapp CL, Dennis MA, Parker SH, Sisney GA. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology 1995;196(1):123-134.
80. Gordon PB, Goldenberg SL. Malignant breast masses detected only by ultrasound: A retrospective review. Cancer 1995;76(4):626-630.
81. Kolb TM, Lichy J, Newhouse JH. Occult cancer in women with dense breasts: detection with screening US-diagnostic yield and tumor characteristics. Radiology 1998; 207(1):191-199.
82. Kaplan SS. Clinical utility of bilateral whole-breast US in the evaluation of women with dense breast tissue. Radiology 2001; 221(3):641-649.
83. Corsetti V, Ferrari A, Ghirardi M, et al. Role of ultrasonography in detecting mammographically occult breast carcinoma in women with dense breasts. Radiol Med (Torino) 2006;111(3):440-448.
84. Berg WA, Blume JD, Cormack JB, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 2008;299(18):2151-2163.
85. Berg WA, Blume JD, Cormack JB, Mendelson EB. Operator dependence of physician-performed whole-breast US: lesion detection and characterization. Radiology 2006;241(2):355-365.
86. Hooley RJ, Greenberg KL, Stackhouse RM, Geisel JL, Butler RS, Philpotts LE. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41. Radiology 2012;265(1):59-69.
87. Weigert J, Steenbergen S. The Connecticut experiment: The role of ultrasound in the screening of women with dense breasts. Breast J 2012;18(6):517-522.
88. Parris T, Wakefield D, Frimmer H. Real world performance of screening breast ultrasound following enactment of Connecticut Bill 458. Breast J 2013;19(1):64-70.
89. Kaplan SS. Automated whole breast ultrasound. Radiol Clin North Am 2014;52(3): 539-546.
90. Skaane P, Gullien R, Eben EB, Sandhaug M, Schulz-Wendtland R, Stoeblen F. Interpretation of automated breast ultrasound (ABUS) with and without knowledge of mammography: A reader performance study. Acta Radiol doi:10.1177/0284185114528835. Published online March 28, 2014.
91. Stelling CB, Wang PC, Lieber A, Mattingly SS, Griffen WO, Powell DE. Prototype coil for magnetic resonance imaging of the female breast: Work in progress. Radiology 1985;154(2):457-462.
92. Heywang SH, Hahn D, Schmidt H, et al. MR imaging of the breast using gadolinium-DTPA. J Comput Assist Tomogr 1986; 10(2):199-204.
93. Kaiser W. MRI of the female breast: First clinical results. Arch Int Physiol Biochim 1985;93(5):67-76.
94. Tan JE, Orel SG, Schnall MD, Schultz DJ, Solin LJ. Role of magnetic resonance imaging and magnetic resonance imaging-guided surgery in the evaluation of patients with early-stage breast cancer for breast conservation treatment. Am J Clin Oncol 1999;22(4):414-418.
95. Esserman L, Hylton N, Yassa L, Barclay J, Frankel S, Sickles E. Utility of magnetic resonance imaging in the management of breast cancer: Evidence for improved preoperative staging. J Clin Oncol 1999;17(1):110-119.
96. Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 2001;220(1): 13-30.
97. Abraham DC, Jones RC, Jones SE, et al. Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging. Cancer 1996;78(1):91-100.
98. Gilles R, Guinebretière JM, Toussaint C, et al. Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology 1994;191(3):633-638.
99. Orel SG, Weinstein SP, Schnall MD, et al. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology 1999;212(2):543-549.
100. Morris EA, Schwartz LH, Dershaw DD, van Zee KJ, Abramson AF, Liberman L. MR imaging of the breast in patients with occult primary breast carcinoma. Radiology 1997;205(2):437-440.
101. Brenner RJ, Rothman BJ. Detection of primary breast cancer in women with known adenocarcinoma metastatic to the axilla: use of MRI after negative clinical and mammographic examination. J Magn Reson Imaging 1997;7(6):1153-1158.
102. Heywang-Köbrunner SH, Bick U, Bradley WG Jr, et al. International investigation of breast MRI: Results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions. Eur Radiol 2001;11(4):531-546.
103. Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-Analysis in detection of multifocal and multicentric cancer. J Clin Oncol 2008;26(19):3248-3258.
104. Turnbull L, Brown S, Harvey I, et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: A randomised controlled trial. Lancet 2010;375(9714):563-571.
105. Brasic N, Wisner DJ, Joe BN. Breast MR imaging for extent of disease assessment in patients with newly diagnosed breast cancer. Magn Reson Imaging Clin N Am 2013;21(3):519-532.
106. Hylton NM, Blume JD, Bernreuter WK, et al. Locally advanced breast cancer: MR imaging for prediction of response to neo adjuvant chemotherapy-results from ACRIN 6657/I-SPY TRIAL. Radiology 2012; 263(3):663-672.
107. Ojeda-Fournier H, de Guzman J, Hylton N. Breast magnetic resonance imaging for monitoring response to therapy. Magn Reson Imaging Clin N Am 2013;21(3):533-546.
108. Jafri NF, Newitt DC, Kornak J, Esserman LJ, Joe BN, Hylton NM. Optimized breast MRI functional tumor volume as a biomarker of recurrence-free survival following neoadjuvant chemotherapy. J Magn Reson Imaging 2014;40(2):476-482.
109. Partridge SC, Gibbs JE, Lu Y, et al. MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am J Roentgenol 2005;184(6):1774-1781.
110. Piccoli CW. The specificity of contrastenhanced breast MR imaging. Magn Reson Imaging Clin N Am 1994;2(4):557-571.
111. Heywang-Köbrunner SH, Viehweg P, Heinig A, Küchler C. Contrast-enhanced MRI of the breast: Accuracy, value, controversies, solutions. Eur J Radiol 1997;24(2):94-108.
112. Kuhl CK, Schild HH. Dynamic image interpretation of MRI of the breast. J Magn Reson Imaging 2000;12(6):965-974.
113. Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging: Are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999;211(1):101-110.
114. Kvistad KA, Rydland J, Vainio J, et al. Breast lesions: Evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2∗-weighted first-pass perfusion MR imaging. Radiology 2000;216(2): 545-553.
115. Kelcz F, Santyr GE, Cron GO, Mongin SJ. Application of a quantitative model to differentiate benign from malignant breast lesions detected by dynamic, gadolinium-enhanced MRI. J Magn Reson Imaging 1996;6(5): 743-752.
116. Boetes C, Barentsz JO, Mus RD, et al. MR characterization of suspicious breast lesions with a gadolinium-enhanced Turbo FLASH subtraction technique. Radiology 1994;193(3):777-781.
117. Lehman CD, Isaacs C, Schnall MD, et al. Cancer yield of mammography, MR, and US in high-risk women: prospective multiinstitution breast cancer screening study. Radiology 2007;244(2):381-388.
118. Gilbert FJ, Warren RM, Kwan-Lim G, et al. Cancers in BRCA1 and BRCA2 carriers and in women at high risk for breast cancer: MR imaging and mammographic features. Radiology 2009;252(2): 358-368.
119. Kuhl CK, Schmutzler RK, Leutner CC, et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 2000;215(1):267-279.
120. Sardanelli F, Podo F, D'Agnolo G, et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology 2007;242(3): 698-715.
121. Berg WA, Zhang Z, Lehrer D, et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA 2012; 307(13):1394-1404.
122. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007;57(2): 75-89.
123. Lee CH, Dershaw DD, Kopans D, et al. Breast cancer screening with imaging: Recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol 2010;7(1):18-27.
124. Berg WA, Anderson ND, Zerhouni EA, Chang BW, Kuhlman JE. MR imaging of the breast in patients with silicone breast implants: normal postoperative variants and diagnostic pitfalls. AJR Am J Roentgenol 1994;163(3):575-578.
125. Gorczyca DP, Sinha S, Ahn CY, et al. Silicone breast implants in vivo: MR imaging. Radiology 1992;185(2):407-410.
126. Ikeda DM, Borofsky HB, Herfkens RJ, Sawyer-Glover AM, Birdwell RL, Glover GH. Silicone breast implant rupture: pitfalls of magnetic resonance imaging and relative efficacies of magnetic resonance, mammography, and ultrasound. Plast Reconstr Surg 1999;104(7):2054-2062.
127. Brenner RJ. Evaluation of breast silicone implants. Magn Reson Imaging Clin N Am 2013;21(3):547-560.
128. Berg WA, Caskey CI, Hamper UM, et al. Single-And double-lumen silicone breast implant integrity: prospective evaluation of MR and US criteria. Radiology 1995; 197(1):45-52.
129. Gershon-Cohen J, Schorr S. The diagnostic problems of isolated, circumscribed breast tumors. Am J Roentgenol Radium Ther Nucl Med 1969;106(4):863-870.
130. Dodd GD, Fry K, Delany W. Pre-operative localization of occult carcinoma of the breast. In: Nealon TF Jr, ed. Management of the patient with cancer. Philadelphia, Pa: Saunders, 1965; 88-113.
131. Libshitz HI, Feig SA, Fetouh S. Needle localization of nonpalpable breast lesions. Radiology 1976;121(3 Pt. 1):557-560.
132. Kopans DB, Lindfors K, McCarthy KA, Meyer JE. Spring hookwire breast lesion localizer: use with rigid-compression mammographic systems. Radiology 1985;157(2):537-538.
133. Homer MJ. Nonpalpable breast lesion localization using a curved-end retractable wire. Radiology 1985;157(1):259-260.
134. Kwasnik EM, Sadowsky NL, Vollman RW. An improved system for surgical excision of needle-localized nonpalpable breast lesions. Am J Surg 1987;154(5):476-477.
135. Morris EA, Liberman L, Dershaw DD, et al. Preoperative MR imaging-guided needle localization of breast lesions. AJR Am J Roentgenol 2002;178(5):1211-1220.
136. Kopans DB, Meyer JE, Lindfors KK, Bucchianeri SS. Breast sonography to guide cyst aspiration and wire localization of occult solid lesions. AJR Am J Roentgenol 1984; 143(3):489-492.
137. Sanders LM, Kalisher L, Trikha S. Needle localization using a stereotactic table: A reassessment. AJR Am J Roentgenol 2000; 174(6):1689-1690.
138. Liberman L, Feng TL, Dershaw DD, Morris EA, Abramson AF. US-guided core breast biopsy: use and cost-effectiveness. Radiology 1998;208(3):717-723.
139. Lindfors KK, Rosenquist CJ. Needle core biopsy guided with mammography: A study of cost-effectiveness. Radiology 1994;190(1): 217-222.
140. Nordenström B, Ryden H, Svane G. Breast. In: Zornoza J, ed. Percutaneous needle biopsy. Baltimore, Md: Williams & Wilkins, 1981; 43-51.
141. Azavedo E, Svane G, Auer G. Stereotactic fine-needle biopsy in 2594 mammographically detected non-palpable lesions. Lancet 1989;1(8646):1033-1036.
142. Svane G, Silfverswärd C. Stereotaxic needle biopsy of non-palpable breast lesions: cytologic and histopathologic findings. Acta Radiol Diagn (Stockh) 1983;24(4):283-288.
143. Nordenström B. Stereotaxic screw needle biopsy of nonpalpable breast lesions. In: Westinghouse W, Logan M, eds. Breast carcinoma: The radiologist's expanded role. New York, NY: Wiley, 1977; 313-318.
144. Fornage BD, Faroux MJ, Simatos A. Breast masses: US-guided fine-needle aspiration biopsy. Radiology 1987;162(2):409-414.
145. Pisano ED, Fajardo LL, Tsimikas J, et al. Rate of insufficient samples for fineneedle aspiration for nonpalpable breast lesions in a multicenter clinical trial: The Radiologic Diagnostic Oncology Group 5 Study. The RDOG5 investigators. Cancer 1998;82(4):679-688.
146. Ciatto S, Rosselli Del Turco M, Bravetti P. Nonpalpable breast lesions: stereotaxic fine-needle aspiration cytology. Radiology 1989;173(1):57-59.
147. Parker SH, Burbank F. A practical approach to minimally invasive breast biopsy. Radiology 1996;200(1):11-20.
148. D'Orsi CJ, Mendelson EB. Interventional breast ultrasonography. Semin Ultrasound CT MR 1989;10(2):132-138.
149. Parker SH, Lovin JD, Jobe WE, et al. Stereotactic breast biopsy with a biopsy gun. Radiology 1990;176(3):741-747.
150. Parker SH, Jobe WE, Dennis MA, et al. US-guided automated large-core breast biopsy. Radiology 1993;187(2):507-511.
151. Parker SH, Burbank F, Jackman RJ, et al. Percutaneous large-core breast biopsy: A multi-institutional study. Radiology 1994;193(2):359-364.
152. Jackman RJ, Nowels KW, Shepard MJ, Finkelstein SI, Marzoni FA Jr. Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia. Radiology 1994;193(1):91-95.
153. Liberman L, Dershaw DD, Rosen PP, Cohen MA, Hann LE, Abramson AF. Stereotaxic core biopsy of impalpable spiculated breast masses. AJR Am J Roentgenol 1995;165(3):551-554.
154. Fajardo LL, Pisano ED, Caudry DJ, et al. Stereotactic and sonographic largecore biopsy of nonpalpable breast lesions: Results of the Radiologic Diagnostic Oncology Group V study. Acad Radiol 2004;11(3):293-308.
155. Demartini WB, Eby PR, Peacock S, Lehman CD. Utility of targeted sonography for breast lesions that were suspicious on MRI. AJR Am J Roentgenol 2009;192(4):1128-1134.
156. Destounis S, Arieno A, Somerville PA, et al. Community-based practice experience of unsuspected breast magnetic resonance imaging abnormalities evaluated with second-look sonography. J Ultrasound Med 2009;28(10):1337-1346.
157. Meissnitzer M, Dershaw DD, Lee CH, Morris EA. Targeted ultrasound of the breast in women with abnormal MRI findings for whom biopsy has been recommended. AJR Am J Roentgenol 2009;193(4):1025-1029.
158. Candelaria R, Fornage BD. Second-look US examination of MR-detected breast lesions. J Clin Ultrasound 2011;39(3):115-121.
159. Abe H, Schmidt RA, Shah RN, et al. MRdirected ("second-look") ultrasound examination for breast lesions detected initially on MRI: MR and sonographic findings. AJR Am J Roentgenol 2010;194(2):370-377.
160. Monticciolo DL. Postbiopsy confirmation of MR-detected lesions biopsied using ultrasound. AJR Am J Roentgenol 2012;198(6): W618-W620.
161. Orel SG, Rosen M, Mies C, Schnall MD. MR imaging-guided 9-gauge vacuum-Assisted core-needle breast biopsy: initial experience. Radiology 2006;238(1):54-61.
162. Lehman CD, Aikawa T. MR-guided vacuumassisted breast biopsy: Accuracy of targeting and success in sampling in a phantom model. Radiology 2004;232(3):911-914.
163. Kuhl CK, Morakkabati N, Leutner CC, Schmiedel A, Wardelmann E, Schild HH. MR imaging-guided large-core (14-gauge) needle biopsy of small lesions visible at breast MR imaging alone. Radiology 2001;220(1): 31-39.
164. Schnall MD, Orel SG, Connick TJ. MR guided biopsy of the breast. Magn Reson Imaging Clin N Am 1994;2(4):585-589.
165. Liberman L, Morris EA, Dershaw DD, Thornton CM, Van Zee KJ, Tan LK. Fast MRI-guided vacuum-Assisted breast biopsy: initial experience. AJR Am J Roentgenol 2003;181(5):1283-1293.
166. Kuhl CK, Elevelt A, Leutner CC, Gieseke J, Pakos E, Schild HH. Interventional breast MR imaging: clinical use of a stereotactic localization and biopsy device. Radiology 1997;204(3):667-675.
167. Orel SG, Schnall MD, Newman RW, Powell CM, Torosian MH, Rosato EF. MR imaging-guided localization and biopsy of breast lesions: initial experience. Radiology 1994;193(1):97-102.
168. Friedewald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA 2014;311(24):2499-2507.
169. Rafferty EA, Park JM, Philpotts LE, et al. Assessing radiologist performance using combined digital mammography and breast tomosynthesis compared with digital mammography alone: Results of a multicenter, multireader trial. Radiology 2013;266(1): 104-113.
170. Kopans DB. Digital breast tomosynthesis from concept to clinical care. AJR Am J Roentgenol 2014;202(2):299-308.
171. Meisamy S, Bolan PJ, Baker EH, et al. Neo adjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo 1H MR spectroscopy-A pilot study at 4 T. Radiology 2004;233(2):424-431.
172. Bolan PJ. Magnetic resonance spectroscopy of the breast: current status. Magn Reson Imaging Clin N Am 2013;21(3): 625-639.
173. Stanwell P, Gluch L, Clark D, et al. Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T. Eur Radiol 2005;15(5):1037-1043.
174. Woodhams R, Ramadan S, Stanwell P, et al. Diffusion-weighted imaging of the breast: principles and clinical applications. Radio Graphics 2011;31(4):1059-1084.
175. Partridge SC, McDonald ES. Diffusion weighted magnetic resonance imaging of the breast: protocol optimization, interpretation, and clinical applications. Magn Reson Imaging Clin N Am 2013;21(3):601-624.
176. Partridge SC, Rahbar H, Murthy R, et al. Improved diagnostic accuracy of breast MRI through combined apparent diffusion coefficients and dynamic contrast-enhanced kinetics. Magn Reson Med 2011;65(6): 1759-1767.
177. Kuhl CK, Schrading S, Strobel K, Schild HH, Hilgers RD, Bieling HB. Abbreviated breast magnetic resonance imaging (MRI): First postcontrast subtracted images and maximum-intensity projection-A novel approach to breast cancer screening with MRI. J Clin Oncol 2014;32(22):2304-2310.
178. Mango V, Jochelson M, Abramson A, Dershaw DD, Lee C, Morris E. Screening breast MRI: how many sequences are needed? [abstr]. In: Radiological Society of North America Scientific Assembly and Annual Meeting Program. Oak Brook, Ill: Radiological Society of North America, 2012; 239.
179. Kukreti S, Cerussi AE, Tanamai W, Hsiang D, Tromberg BJ, Gratton E. Characterization of metabolic differences between benign and malignant tumors: high-spectralresolution diffuse optical spectroscopy. Radiology 2010;254(1):277-284.
180. Cerussi AE, Jakubowski D, Shah N, et al. Spectroscopy enhances the information content of optical mammography. J Biomed Opt 2002;7(1):60-71.
181. Jiang S, Pogue BW, Carpenter CM, et al. Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes. Radiology 2009;252(2):551-560.
182. Zhi W, Gu X, Qin J, et al. Solid breast lesions: clinical experience with US-guided diffuse optical tomography combined with conventional US. Radiology 2012;265(2): 371-378.
183. Pogue BW, Poplack SP, McBride TO, et al. Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: pilot results in the breast. Radiology 2001;218(1): 261-266.
184. Fang Q, Selb J, Carp SA, et al. Combined optical and X-ray tomosynthesis breast imaging. Radiology 2011;258(1):89-97.
185. Poplack SP, Tosteson TD, Wells WA, et al. Electromagnetic breast imaging: Results of a pilot study in women with abnormal mammograms. Radiology 2007;243(2):350-359.
186. Lindfors KK, Boone JM, Newell MS, D'Orsi CJ. Dedicated breast computed tomography: The optimal cross-sectional imaging solution? Radiol Clin North Am 2010; 48(5):1043-1054.
187. Kalender WA, Beister M, Boone JM, Kolditz D, Vollmar SV, Weigel MC. Highresolution spiral CT of the breast at very low dose: concept and feasibility considerations. Eur Radiol 2012;22(1):1-8.
188. Prionas ND, Lindfors KK, Ray S, et al. Contrast-enhanced dedicated breast CT: initial clinical experience. Radiology 2010;256(3): 714-723.
189. Fallenberg EM, Dromain C, Diekmann F, et al. Contrast-enhanced spectral mammography versus MRI: initial results in the detection of breast cancer and assessment of tumour size. Eur Radiol 2014;24(1): 256-264.
190. Jochelson M. Contrast-enhanced digital mammography. Radiol Clin North Am 2014; 52(3):609-616.
191. Jochelson MS, Dershaw DD, Sung JS, et al. Bilateral contrast-enhanced dual-energy digital mammography: Feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma. Radiology 2013;266(3): 743-751.